医学
淋巴水肿
吸脂
外科
阶段(地层学)
前瞻性队列研究
癌症
乳腺癌
内科学
生物
古生物学
作者
Tobias Karlsson,Helen Mackie,Louise Koelmeyer,Asha Heydon-White,Robyn Ricketts,Kim Toyer,John Boyages,Håkan Brorson,Terry Lam
标识
DOI:10.1097/prs.0000000000010612
摘要
Liposuction for International Society of Lymphology (ISL) late stage II or III limb lymphedema is an established surgical option to remove excessive adipose tissue deposition and has been performed in Australia since 2012 at the Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Macquarie University.Between May 2012 and May 2017, 72 patients with unilateral primary or secondary lymphedema of the arm or leg underwent suction-assisted lipectomy using the Brorson protocol. This prospective study presents 59 of these patients who had consented to research with a five-year follow-up.Of the 59 patients, 54 (92%) were women, 30 (51%) had leg lymphedema and 29 (49%) had arm lymphedema. For arm patients, the median preoperative volume difference between the lymphedematous and the contralateral arm was 1061 mL, which reduced to 79 mL one year after surgery and to 22 mL five years after surgery. For leg patients, the median preoperative volume difference was 3447 mL, which reduced to 263 mL one year after surgery but increased to 669 mL five years after surgery.Suction-assisted lipectomy is a long-term option for the management of selected patients with ISL late stage II or III limb lymphedema when conservative management can offer no further improvement.
科研通智能强力驱动
Strongly Powered by AbleSci AI